Clinical Trial: A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801223) titled 'A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection' on Jan. 16.

Brief Summary: The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections

Study Start Date: Jan. 31

Study Type: INTERVENTIONAL

Condition: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)

Intervention: DRUG: ...